ghk-cu injection fda approved 100 mg Research Peptide & COA Specification:10 mg shiphero-trigger-20240828 FOXO4-DRI - Averix Labs

ghk-cu injection fda approved 100 mg Research Peptide & COA Specification:10 mg shiphero-trigger-20240828 FOXO4-DRI - Averix Labs

FOXO4-DRI - Averix Labs

There is meaningful interest in GHK-Cu for skin regeneration and remodeling, but patients should know the evidence is still not the same as having large, acne-scar-specific human trials proving strong visible improvement in post-Accutane scarring

shiphero-trigger-20240828

Specification:10 mg

Jack Khattar, president & CEO of Supernus, said the company “remain[s] committed to bringing SPN-830 to the market” and will work with the FDA to address the issues identified in the CRL and resubmit the NDA